The Rosalind Franklin Institute celebrates important milestone

Photograph shows: Tim Venables, RFI, Andrew Bourne, EPSRC, Barbara Ghinelli, STFC, Andrew Livingston, RFI, Jim Naismith, RFI.
Rosalind Frank Institute

The Rosalind Franklin Institute celebrates important milestone

The Rosalind Franklin Institute, a new £103 million national institute which will develop new technologies for life science, is celebrating the formal commitment of ten university partners and the research council Science and Technology Facilities Council (STFC)  to a partnership within the Institute.

The Institute will develop and apply new technologies to enable new insight into molecular and cellular biology, with activities coordinated across the UK in partner spokes and at the Harwell Campus.

Speaking at Vertex Pharmaceuticals, an international pharmaceutical company with a research base at Milton Park, Oxfordshire, the interim academic lead for the Institute, Professor Andrew Livingston said: “We are extremely pleased to have reached this important milestone. A huge amount of work has been carried out in the background alongside the formal legal agreement, working with industry partners and our academic colleagues to ensure that the Rosalind Franklin Institute will produce the right technologies to solve challenges in life science which are too complex for one organisation to tackle alone.”

The Institute’s £40 million hub on the Harwell Campus will house much of its core equipment and emerging technologies, and link to neighbouring national facilities on the campus. Opening in 2020 with space for 150 researchers, construction of the new building will start this Autumn.

Dr Gillian Burgess, Site Head & VP, Research at Vertex Pharmaceuticals Oxford said: “For nearly 20 years, Vertex has chosen to invest in the UK. We have made this deep and longstanding commitment to the UK because we know this country is a great place to carry out drug discovery.

“We also know first-hand just how critical cross-disciplinary collaboration is to the hunt for new treatments and therapies to treat serious disease. The Rosalind Franklin Institute will bring together physical scientists, engineers and life scientists to find solution to some of the key challenges in the health and life sciences.”

Announcements on the permanent institute chair, director and science leads are expected soon. These appointments will take on the next phase of the Institute’s development, delivering the roadmaps for the science themes and developing new collaborations with industry and academic partners.

Partner Institutions:

  • University of Birmingham
  • University of Cambridge
  • University of Edinburgh
  • Imperial College London
  • University of Leeds
  • Kings College London
  • University of Manchester
  • University of Oxford
  • University of Southampton
  • University College London (UCL)